Floatz logo

Dolutegravir

Cardiovascular Abnormalities

Augusta UniversitySmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Cardiovascular Abnormalities cohort.

Asset / SponsorPhaseRating
Tirzepatide
University Medical Centre Ljubljana
Phase 4BB
Sildenafil
Mayo Clinic
Phase 3B
Fibrinogen Concentrate Human
IRCCS Policlinico S. Donato
Phase 2CCC
Prothrombin Complex Concentrate, Human
IRCCS Policlinico S. Donato
Phase 2CCC
CARVEDILOL
Northwestern University
Phase 2CCC

View all 10 →

Same molecule, other indications

Dolutegravir is also rated in:

HIV infectious diseaseDormant
BBB
Indicative ·
76 / 100
View asset →
lipodystrophyDormant
BBB
Indicative ·
73 / 100
View asset →
HIV InfectionsDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →